BerGenBio ASA (BRRGF) Stock Analysis
DELISTED
What happened to BerGenBio ASA (BRRGF) stock?
BerGenBio ASA (BRRGF) no longer trades on public markets. The figures below are historical and are not a current quote.
- Status:
- Delisted — no longer trades
Market cap $9.49B is the value of all shares combined.
For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
BerGenBio ASA (BRRGF). BerGenBio ASA is a clinical-stage biopharmaceutical company based in Norway, focused on developing drugs for immune-evasive, drug-resistant, and metastatic cancers, as well as respiratory diseases.
Last analyzed: Jun 13, 2026Dated analysis: the newest financial statements on file are 25 months old (Sep 1, 2024), so the figures and score below describe that period, not today.
BerGenBio ASA (BRRGF) Healthcare & Pipeline Overview
BRRGF OTC Market Information
BRRGF trades on the OTC Other market tier of OTC Markets.
- OTC Tier: OTC Other
More about this archive record
Can I still buy BRRGF shares?
No. BRRGF stopped trading on public markets, so the shares are not available through a broker. Anything you see quoted for BRRGF elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before BRRGF stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to BerGenBio ASA. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.